Quantum Dot Nanocarriers for Drug Delivery compiles the latest advances in the development and application of QD nanocarriers for delivery of a range of therapeutic agents. QDs are widely accepted because of their dominant striking characteristics including biocompatibility, photoluminescence, morphology, size, and stability. This book systematically reviews the benefits and challenges of using QDs in drug delivery applications, evaluating their toxicity, safety, preclinical and clinical aspects. Quantum Dot Nanocarriers for Drug Delivery is of interest to a broad audience, including researchers and academics working in the fields of biomaterials, nanotechnology, pharmaceutical science and biomedical engineering.
Table of Contents
1. History, introduction and types of quantum dots2. Synthesis methods of quantum dots
3. Characterizations of quantum dots
4. Quantum dots for enhanced anticancer drug delivery
5. Quantum dots as an advanced nano system for cancer theranostics
6. Quantum dots in photodynamic therapy
7. Quantum dots for enhanced antibacterial performance
8. Quantum dots for enhanced wound healing
9. Quantum dots for anti-diabetic drugs delivery
10. Quantum dots for treatment of neurodegenerative disorders
11. Quantum dots in vaccination and immunization
12. Carbon quantum dots in drug delivery
13. Functionalized quantum dots in drug delivery
14. Hybrid quantum dots in drug delivery
15. Bioinspired quantum dots in drug delivery
16. Quantum dots in pharmaceutical and biomedical analysis
17. Safety, toxicity, pre-clinical and clinical aspects of quantum dots
18. Future prospects and concluding remarks of quantum dots
Authors
Prashant Kesharwani Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as "USERN Laureate award�, most prestigious "Ramanujan Fellowship Award�. He actively participates in outreach and scientific dissemination for the service of the wider community.
Surender Singh Professor, Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Dr. Surender Singh is a Professor at the Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. He has been a faculty member of pharmacology for more than thirty-two years of which seventeen years he has worked at All India Institute of Medical Sciences, New Delhi. He has authored ten books, and over 140 scientific papers in indexed journals; he has completed over 35 research projects funded by different research funding Government agencies e.g., JSPS, UCL, ICMR, DST, DBT, UGC, AIIMS, AYUSH. Dr Singh is the recipient of many awards, including the ICMR for Biomedical Research, 2017. He has made significant contributions in the field of pharmacotherapy of inflammatory disorders, as well as the application of nanotechnologies for use in drug delivery. He is a Fellow of National Academy of Medical Sciences (FAMS), India, Fellow of Royal Society of Chemistry (FRSC), United Kingdom, Fellow of International Medical Science Academy, India (FIMSA) and Fellow of Institution of Chemists (FIC), India.
